Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 3/20 | 0.65 |
| ▸ | MC5R | P33032 | 2/20 | 0.65 |
| ▸ | MC3R | P41968 | 2/20 | 0.65 |
| ▸ | MC1R | Q01726 | 2/20 | 0.65 |
| ▸ | NPY1R | P25929 | 1/20 | 0.63 |
| ▸ | NPY2R | P49146 | 1/20 | 0.63 |
| ▸ | NPY4R | P50391 | 1/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.63 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.62 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.61 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.60 |
| ▸ | GLP1R | P43220 | 5/20 | 0.58 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edratide SCHEMBL29355439 | 0.97 | IL23R (0.62) | MC4RMC5RMC3RMC1RNPY1R | |
| SCHEMBL30607498 | 0.89 | NPY2R (0.70) | MC4RMC5RMC3RMC1RNPY1R | |
| SCHEMBL30906368 | 0.89 | NPY2R (0.65) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31683320 | 0.88 | NPY2R (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30618038 | 0.88 | IL23R (0.67) | MC4RMC5RMC3RMC1RNPY1R | |
| SCHEMBL30906424 | 0.88 | NPY2R (0.70) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30721554 | 0.87 | NPY2R (0.76) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30494418 | 0.87 | NPY2R (0.67) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30658239 | 0.86 | NPY1R (0.69) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30712911 | 0.85 | NPY1R (0.61) | NPY1RNPY2RNPY4RNPY5RCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4302098-A1 | SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY | Regeneron Pharmaceuticals, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-110139659-B | Peptides for the treatment of sjogren's syndrome | 耶达研究及发展有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20220404369-A1 | SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY | REGENERON PHARMACEUTICALS, INC. | 2022-12-22 | — | — | US | disclosed |
| EP-4090685-A1 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE | TrueBinding, Inc. (US) | 2022-11-23 | — | — | EP | disclosed |
| WO-2022187323-A1 | SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY | REGENERON PHARMACEUTICALS, INC. (US) | 2022-09-09 | — | — | WO | disclosed |